IDH1 and neoplasm: The vehicle + ABT group was indistinguishable from the vehicle alone group (i.e. without ABT, P = 0.99), demonstrating that the observed anti-tumor efficacy was mediated by our IDH1 mutant-selective compounds rather than ABT.